Cellomics announces Mr. Andy A. Liu as new Group CEO of …
Hong Kong, Oct. 24, 2023 /PRNewswire/ — Cellomics, the leader in liquid biopsy technology for cancer screening and precision diagnosis, is pleased to announce the appointment of Mr. Andy A. Liu as the new Group CEO of the company.. With over 25 years of healthcare experience, Mr. Liu brings a wealth of knowledge and expertise to …